TRIM31 and breast carcinoma: To verify whether TRIM31 was involved in the malignant progression of breast cancer cells in vivo, we first established a xenograft tumor model by subcutaneous injection of TRIM31 or TRIM31-C36A-overexpressing ZR-75-30 cells and control cells into nude mice, respectively.